Skip to content
Excelsior
About Excelsior Medical
Enterprise Spirit
Development Strategy
Related Company
Overseas Business
Company History
Product Description
Hemodialysis / Plasma Exchange
Blood Bag
Artificial Stoma
Health Appliances
ESG
Investors
Enterprise Recruitment
Contact Us
繁體中文
Investors
Investor Zone
Material Information
Board of Directors
Financial Information
Monthly Revenue
Financial Statements
Shareholder Services
Shareholders’ Meeting
Institutional Investor Conference
Dividend
Stock Quotes
Stock Transfer Agent and Registrar
Contacts
Stakeholders
Investor
Material Information
To announce the change of deputy general manager of the company.
2023-12-29
To announce the change of acting spokesperson of the company.
2023-12-29
The Board of Directors approved Q3 2023 consolidated financial statements.
2023-11-07
The Company is invited to attend an institutional investor conference hosted by President Securities on September 21, 2023.
2023-09-20
Announcement of the resolution by the Board of Directors for capital reduction in cash on behalf of subsidiary Excelsior Healthcare Co., Limited
2023-08-08
Announcement of the resolution by the Board of Directors for capital reduction in cash on behalf of subsidiary Excelsior Medical (HK) Co.,Ltd.
2023-08-08
For restructuring of the group’s investment structure,the BOD approved to acquire ASIA BEST LIFE CARE TECHNOLOGY CO. LTD.’s common shares from Excelsior Medical (HK) Co.,Ltd.
2023-08-08
Announcement of the decision by the Board of Directors for the ex-rights record date of stock dividends.
2023-08-08
The Board of Directors approved Q2 2023 consolidated financial statements.
2023-08-08
Announcement of delay of cash dividend for part areas.
2023-08-02